Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Ketamine Infusion Therapy Now Available in Carlsbad New Mexico

Klarisana has opened its first New Mexico center in Carlsbad. Now, residents of southeast New Mexico have access to ketamine infusion therapy for the treatment of depression, PTSD, anxiety, alcohol abuse, and chronic pain.


News provided by

Klarisana

Sep 14, 2018, 11:00 ET

Share this article

Share toX

Share this article

Share toX


CARLSBAD, N.M., Sept. 14, 2018 /PRNewswire-PRWeb/ -- One of the country's most respected ketamine infusion providers, has just opened a new center in Carlsbad, New Mexico. Klarisana, which is well known to residents of central Texas with its established ketamine infusion centers in Austin and San Antonio, has now crossed its western border to offer ketamine therapy to patients in southeast New Mexico. This marks the first center that Klarisana has opened outside of Texas. Gerson Barahona, Klarisana's Operations Director, marked the event by saying, "we have worked very hard over the last several years to perfect the process of administering ketamine for depression, anxiety, post-traumatic stress disorder (PTSD), and various forms of chronic pain. We have a great process which allows us to provide an effective and evidence-based treatment program. We are thrilled to bring this paradigm-changing treatment to the Carlsbad and Roswell, New Mexico areas.

Klarisana's Clinical Director in Carlsbad is Shannon Roper, a lifelong resident of Carlsbad and an experienced Family Nurse Practitioner. Roper operates her own practice, Roper's Health Oasis which is a key fixture of the healthcare community in Carlsbad. Klarisana will be operating as an independent practice out of Roper's clinic. Roper said, "I am really happy to join the Klarisana family. For the last several years, I have been closely following the research regarding what ketamine can do for mental health conditions and chronic pain. There is a definite need for this in our area and I wanted to partner with an organization that is 'doing it right.' Klarisana has really demonstrated that they are the 'thought leaders' when it comes to ketamine. Ketamine has been around for over forty years but its use in the outpatient setting is relatively new. What really drew me to Klarisana is that they are very open about what their treatment protocols are and base them on the best medical evidence. Some other ketamine centers tout that they have trademarked formulations and 'proprietary blends' of ketamine. These centers quote the positive results of internal 'research' that supports their protocols but won't actually show you the evidence. That model just doesn't feel right. Klarisana is a very straight-shooting organization that doesn't engage in marketing gimmicks and 'smoke and mirrors' kind of self-promotion."

Klarisana has brought its cutting edge ketamine therapy to Carlsbad, New Mexico

Post this

Klarisana opened its first center in San Antonio back in 2015. The company later expanded to have a very busy center in Austin, Texas as well. Klarisana's founder and Medical Director, Dr. Carl J. Bonnett, MD says, "ketamine represents a very disruptive technology when it comes to the treatment of mental health conditions and chronic pain. Many patients with chronic pain are locked into a destructive feedback loop called 'central sensitization' where pain leads to more pain which leads to more pain etc. Ketamine blocks the NMDA receptor which is at the heart of this process. The elegant thing about ketamine is that it works through a totally separate process than opioid pain medications. Given the huge crisis in opioid overuse and addiction in the United States, a game-changing therapy like ketamine has huge public health implications."

Bonnett adds, "when it comes to the treatment of depression and other mental health conditions, ketamine has also shown the potential to be a real "game changing" therapy ever since the first study came out in 2000 showing that it can break the cycle of treatment-resistant depression in over 70% of patients. There are two distinctly different schools of thought regarding how ketamine works to treat depression, anxiety, and PTSD. Some clinicians believe that ketamine only works through biochemical pathways and that the alterations in perception and the 'psychedelic' qualities of ketamine infusion therapy are 'side effects' that need to be eliminated. At Klarisana we believe the exact opposite. The alterations in perception can produce a powerful 'transpersonal' experience that...far from being a side effect...is a critical element of how ketamine works. We create a customized dosing strategy for every patient and adjust the dosing in a dynamic fashion. We escalate our doses until we find the dose which creates the optimum transpersonal experience which we call the Psychotropic Therapeutic Response or 'PTR." This dose is unique for each patient. It takes some work to achieve but we have found that this is critical for success. A 'cookie cutter' dosing strategy is just not as effective."

Patients and clinicians in the Carlsbad and Roswell, New Mexico area who want to learn more about Klarisana and what ketamine infusion therapy can do, are encouraged to visit Klarisana's website at Klarisana.com or call the main number at 210-556-1430.

Klarisana - Carlsbad, NM
110 S. Halagueno, STE 8
Carlsbad NM 88220
Klarisana.com

SOURCE Klarisana

Related Links

http://www.klarisana.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.